Friday, October 21, 2016

Boots Chilblain Cream





1. Name Of The Medicinal Product



Chilblain Cream


2. Qualitative And Quantitative Composition









Active ingredient


%w/w




Benzyl alcohol Ph Eur




7.5




Eucalyptus Oil Ph Eur




1.0



3. Pharmaceutical Form



Cream



4. Clinical Particulars



4.1 Therapeutic Indications



To soothe and heal broken and unbroken chilblains.



For topical administration.



4.2 Posology And Method Of Administration



Cream to be applied to affected area and rubbed gently into the skin.



4.3 Contraindications



Known Hypersensitivity to any of the ingredients.



4.4 Special Warnings And Precautions For Use



If symptoms persist, consult your doctor.



For external use only.



Keep all medicines out of the reach of children.



Chilblain Cream contains Arachis oil (peanut oil) and should not be applied by patients known to be allergic to peanut. As there is a possible relationship between allergy to peanut and allergy to Soya, patients with Soya allergy should also avoid Chilblain Cream.



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



None known.



4.6 Pregnancy And Lactation



The safety of chilblain cream during pregnancy and lactation has not been established, but use during these periods is not considered to constitute a hazard.



4.7 Effects On Ability To Drive And Use Machines



No adverse effects known.



4.8 Undesirable Effects



Rarely hypersensitivity reactions.



4.9 Overdose



Excessive application of the product may lead to excessive reddening of the skin. Treatment if necessary need only be symptomatic.



5. Pharmacological Properties



5.1 Pharmacodynamic Properties



Eucalyptus oil has an irritant and rubefacient action on intact skin, providing improved local circulation and a feeling of warmth.



Benzyl alcohol has a weak local anaesthetic activity and reduces the discomfort associated with chilblains.



5.2 Pharmacokinetic Properties



No data available.



5.3 Preclinical Safety Data



There are no preclinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC.



6. Pharmaceutical Particulars



6.1 List Of Excipients



Purified water



Natrosol 250H



Propylene glycol



Triethanolamine



Methyl parahydroxybenzoate



Stearic acid toilet



Cetyl alcohol



Glyceryl monostearate 40-50



Wool fat



Arachis oil



Silicone fluid F111/20



Butylated hydroxyanisole



Propyl parahydroxybenzoate



6.2 Incompatibilities



None



6.3 Shelf Life



36 months



6.4 Special Precautions For Storage



Do not store above 25°C.



6.5 Nature And Contents Of Container



A collapsible, internally lacquered, aluminium tube with an HDPE or polypropylene wadless cap.



Pack size: 35g



6.6 Special Precautions For Disposal And Other Handling



None



7. Marketing Authorisation Holder



The Boots Company PLC



Nottingham



NG2 3AA



8. Marketing Authorisation Number(S)



PL 00014/0132



9. Date Of First Authorisation/Renewal Of The Authorisation



First authorisation: 10 November 1971



Last renewal: 25 July 2002



10. Date Of Revision Of The Text



June 2004




No comments:

Post a Comment